These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


85 related items for PubMed ID: 18018541

  • 1. [Prevention of cardiovascular risk in diabetes].
    Marre M, Duval-Leclercq M, Travert F.
    Rev Prat; 2007 Sep 15; 57(13):1423-30. PubMed ID: 18018541
    [Abstract] [Full Text] [Related]

  • 2. Primary prevention of cardiovascular events and type 2 diabetes: should we prioritize our interventions?
    Sultan A, Thuan JF, Avignon A.
    Diabetes Metab; 2006 Dec 15; 32(6):559-67. PubMed ID: 17296509
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
    Weiss IA, Valiquette G, Schwarcz MD.
    Cardiol Rev; 2009 Dec 15; 17(4):165-75. PubMed ID: 19525678
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hypertension and diabetes mellitus are associated with cardiovascular events in the elderly without cardiovascular disease. Results of a 15-year follow-up in a Mediterranean population.
    Noto D, Cefalù AB, Barbagallo CM, Sapienza M, Cavera G, Nardi I, Pagano M, Vivona N, Notarbartolo A, Averna MR.
    Nutr Metab Cardiovasc Dis; 2009 Jun 15; 19(5):321-6. PubMed ID: 18571394
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH, van der Klauw MM, Wolffenbuttel BH.
    Expert Rev Cardiovasc Ther; 2008 Mar 15; 6(3):323-41. PubMed ID: 18327994
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Diabetes and heart].
    Catargi B.
    Nephrol Ther; 2006 Jan 15; 2 Suppl 1():S17-22. PubMed ID: 17378135
    [Abstract] [Full Text] [Related]

  • 17. Update on diabetes mellitus: prevention, treatment, and association with oral diseases.
    Skamagas M, Breen TL, LeRoith D.
    Oral Dis; 2008 Mar 15; 14(2):105-14. PubMed ID: 18302671
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Mar 15; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 20. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
    Steiner G.
    Am J Cardiol; 2008 Dec 22; 102(12A):28L-33L. PubMed ID: 19084087
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.